WHO urges rapid expansion of new HIV prevention tools amid funding crisis
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
The receipt of this order further strengthens the company's position in the global pharmaceutical market
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
The proposed transaction will be effected as a share swap
Subscribe To Our Newsletter & Stay Updated